Salvage radiation in men after prostate-specific antigen failure and the risk of death.
about
Long-term tolerance and outcomes for dose escalation in early salvage post-prostatectomy radiation therapy.Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy.Quality of Life after Post-Prostatectomy Intensity Modulated Radiation Therapy: Pelvic Nodal Irradiation Is Not Associated with Worse Bladder, Bowel, or Sexual OutcomesReview of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapy.Diagnostic Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Detecting Residual or Recurrent Prostate Cancer After Radical Prostatectomy: A Pooled Analysis of 12 Individual Studies.Does salvage radiation therapy change the biology of recurrent prostate cancer based on PSA doubling times? Results from the SEARCH database.General commentary to the "management of biochemical recurrence after primary localized therapy for prostate cancer" by darwish o. M. And raj g. VManagement of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directionsA prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy.Radiotherapy following radical prostatectomy.What is the possible role of PSA doubling time (PSADT) and PSA velocity (PSAV) in the decision-making process to initiate salvage radiotherapy following radical prostatectomy in patients with prostate cancer?The Role of Radiotherapy After Radical Prostatectomy in Patients with Prostate Cancer.Natural history of 'second' biochemical failure after salvage radiation therapy for prostate cancer: a multi-institution study.Early salvage radiation therapy post-prostatectomy: key considerations.Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer.Advances in Prostate Cancer Magnetic Resonance Imaging and Positron Emission Tomography-Computed Tomography for Staging and Radiotherapy Treatment Planning.Adjuvant Versus Early Salvage Radiation Therapy Following Radical Prostatectomy for Men with Localized Prostate Cancer.A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy.[Begin salvage radiotherapy early after diagnosis of PSA recurrence].Prostatectomy at high-volume centers improves outcomes and lowers the costs of care for prostate cancer.Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy: A propensity score-matched analysis.Elective irradiation of pelvic lymph nodes during postprostatectomy salvage radiotherapy.Multiparametric magnetic resonance imaging-transrectal ultrasound fusion-assisted biopsy for the diagnosis of local recurrence after radical prostatectomy.Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review.Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer-specific death in patients receiving salvage radiation therapy following radical prostatectomy.Defining biochemical recurrence after radical prostatectomy and timing of early salvage radiotherapy : Informing the debate.Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery.
P2860
Q34325482-0675D090-9D71-42FD-B0AD-48E93F681E70Q35195300-547D07BC-4C20-4A0C-B3F7-7D4D6D2A9FBAQ35825924-7EFF2CD4-9CA6-4FB5-9B5B-8126FC67121FQ36010923-60320763-9464-49B2-9CA9-FB3CD99B27A8Q36063296-FC74BE31-69DB-4162-AD8F-0C08715F155BQ36199750-972EFC67-3B4D-4860-AC7D-D44922DA3B3AQ36281753-ED468BCE-E4AA-4B41-98D0-102885B12050Q36760953-3AB331E4-A47C-4A65-8350-ADC084B546C1Q37033549-D10B3C04-1815-4554-8A03-27BD216D7512Q38030597-FCB25647-38A2-455E-861B-CBB148EC1719Q38191927-65FDCFDA-8813-4E71-8C27-6AD62E61DD12Q38602697-A35E4744-CA65-4F7E-8293-C82FA2B363F1Q38674757-2D5AB356-838E-4EDB-9130-43628243DFA1Q38844315-18033294-79A6-48A6-82E0-F19BC71F5FADQ38982759-8359C96A-435A-4BF8-BFEA-2AF5D9513DEAQ39041614-CC96F8AF-15D3-4881-A39A-6CFADC91D353Q39356227-ABA8B71D-364A-4295-ADBB-BB955BAA69E6Q40120703-4AA9ED6F-8626-4C7B-B05D-750C71277C34Q40512483-98FB6572-7FC7-4753-84CF-621FFCD7CCCAQ41051902-3C57BF6F-0B25-4374-8EEA-F99E167ECDD3Q41599603-B2423945-E8DC-4DDE-9B23-80654D252543Q44976719-83EEC068-FC6F-4EE4-8922-1542AA0F9BD4Q47106965-76E30F90-582B-4479-B9B3-163706BDE21AQ47826406-D75886F6-45BA-4772-937C-EAEA2D116AF8Q50861919-8AB3682B-542C-45DF-ABF0-0402F6452931Q51021332-E46923B0-66C4-4D0D-9FE8-CABEEBB04C22Q53260798-82E6E84A-FC96-478A-BAE1-1DB3BD14837C
P2860
Salvage radiation in men after prostate-specific antigen failure and the risk of death.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Salvage radiation in men after prostate-specific antigen failure and the risk of death.
@en
Salvage radiation in men after prostate-specific antigen failure and the risk of death.
@nl
type
label
Salvage radiation in men after prostate-specific antigen failure and the risk of death.
@en
Salvage radiation in men after prostate-specific antigen failure and the risk of death.
@nl
prefLabel
Salvage radiation in men after prostate-specific antigen failure and the risk of death.
@en
Salvage radiation in men after prostate-specific antigen failure and the risk of death.
@nl
P2093
P2860
P356
P1433
P1476
Salvage radiation in men after prostate-specific antigen failure and the risk of death.
@en
P2093
Anthony V D'Amico
Bridget F Koontz
Cary N Robertson
Judd W Moul
Ming Hui Chen
Mitchell S Anscher
Philip J Walther
Shane E Cotter
Thomas J Polascik
W Robert Lee
P2860
P304
P356
10.1002/CNCR.25993
P407
P577
2011-03-22T00:00:00Z